Last reviewed · How we verify

NCT05108792: SPCMD-REA

Continuous Deep Sedation Until Death

Completed Last updated 5 November 2021
What this trial tests

trial testing NO INTERVENTION in Terminal Care in 585 participants. Completed in 1 October 2021.

Timeline
26 February 2021
Primary endpoint
1 October 2021
1 October 2021

Quick facts

Lead sponsorSociété Française d'Anesthésie et de Réanimation
StatusCompleted
Study typeOBSERVATIONAL
Enrollment585
Start date26 February 2021
Primary completion1 October 2021
Estimated completion1 October 2021
Sites64 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Société Française d'Anesthésie et de Réanimation

Who can join

18 and older, any sex, with Terminal Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research is a descriptive observational study conducted in multicenter (intensive care and continuing care units) in France. All data collected is part of the patient record. The main objective is to describe the end-of-life sedative practices following a decision to limit or stop therapy in intensive care unit and continuing care unit.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of NO INTERVENTION

Trials testing the same drug.

Other recruiting trials for Terminal Care

Currently open trials in the same condition.

Other Société Française d'Anesthésie et de Réanimation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05108792.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing